Hydrogenology
Source-linked study record

Hydrogen water consumption prevents osteopenia in ovariectomized rats

Guo JD, Li L, Shi YM, Wang HD, Hou SX. · British Journal of Pharmacology. 2013;168(6):1412-1420.

PreclinicalH₂-rich waterPublished 2013Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Female Sprague-Dawley rats undergoing sham surgery or ovariectomy and receiving ordinary or hydrogen-rich drinking water.

Intervention and dose

Hydrogen-rich water was provided as drinking water for three months after sham surgery or ovariectomy. · Water was saturated at 0.4 MPa for four hours to 1.3±0.2 mg/L, prepared weekly and kept above 0.8 mg/L during daily use.

Duration

Three months of ad-libitum drinking-water exposure.

Reported result

H₂ water preserved multiple femoral and vertebral bone-mass, strength and structural measures after ovariectomy and changed oxidative/inflammatory markers. It did not change body weight, estrogen or plasma pH; vertebral bone area, mechanical energy and trabecular thickness were not reduced by ovariectomy, and several sham-plus-H₂ outcomes were unchanged. Femoral p22phox and serum IL-6 were notable non-significant findings.

Main limitation

Large nominal cohort but individual assays used only n=10-12 per group, preclinical estrogen-depletion model, many surrogate endpoints and no fracture outcome. No funding statement was identified in the article; the authors declared no conflict of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Four-group controlled ovariectomy experiment

Research topic

Musculoskeletal and pain research

Administration form

H₂-rich water

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Female Sprague-Dawley rats undergoing sham surgery or ovariectomy and receiving ordinary or hydrogen-rich drinking water.

Sample

240 rats divided into four groups of 60. Outcome tables report n=10-12 per group, indicating that prespecified subsets were used for individual assays.

Duration

Three months of ad-libitum drinking-water exposure.

Intervention

Hydrogen-rich water was provided as drinking water for three months after sham surgery or ovariectomy.

Hydrogen form

H₂ dissolved in drinking water — H₂ only, not Brown's gas.

Dose or H₂ specification

Water was saturated at 0.4 MPa for four hours to 1.3±0.2 mg/L, prepared weekly and kept above 0.8 mg/L during daily use.

Comparator

Sham-operated and ovariectomized rats drinking ordinary water, plus sham-operated rats drinking H₂-rich water.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Bone mineral content/density, mechanical strength, trabecular morphology, osteoblast/osteoclast surfaces, estrogen, osteocalcin, urinary DPD, oxidative markers, cytokines, NF-κB signalling and NO/eNOS.

Reported result

H₂ water preserved multiple femoral and vertebral bone-mass, strength and structural measures after ovariectomy and changed oxidative/inflammatory markers. It did not change body weight, estrogen or plasma pH; vertebral bone area, mechanical energy and trabecular thickness were not reduced by ovariectomy, and several sham-plus-H₂ outcomes were unchanged. Femoral p22phox and serum IL-6 were notable non-significant findings.

Extraction completeness

The complete free PMC article was checked for all four groups, sample accounting, H₂ concentration and preparation, bone and mechanistic outcomes, positive and null findings, funding and conflict declaration.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Large nominal cohort but individual assays used only n=10-12 per group, preclinical estrogen-depletion model, many surrogate endpoints and no fracture outcome. No funding statement was identified in the article; the authors declared no conflict of interest.

Applies directly to

Ovariectomy-associated osteopenia in rats; it does not establish osteoporosis prevention or fracture reduction in people.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 23121335 · DOI: 10.1111/bph.12036

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.